Group 1 - The core point of the article is that JinHao Medical has announced a restricted stock incentive plan aimed at motivating key personnel, with specific performance targets set for revenue and net profit [1] Group 2 - As of February 4, 2026, JinHao Medical's stock closed at 22.7 yuan, with a market capitalization of 2.235 billion yuan [1] - The stock opened at 22.75 yuan, reached a high of 22.9 yuan, and a low of 22.62 yuan, with a trading volume of 25.5143 million yuan and a turnover rate of 2.03% [1] - The company plans to grant 200,000 shares of restricted stock to three incentive targets at a price of 8.77 yuan per share, with a lock-up period of 12 to 24 months [1] - The performance targets for the company include achieving a minimum revenue of 300 million yuan in 2026 or a cumulative net profit of 55 million yuan over three years, and a minimum revenue of 350 million yuan in 2027 or a cumulative net profit of 90 million yuan over three years [1]
锦好医疗（920925）披露2025年限制性股票激励计划预留权益授予公告，2月4日股价上涨0.09%